Exascale Labs Holdings Inc. income statement XLABW

Annual Quarterly

In fiscal 2026, which ended Jun 30, 2026, Exascale Labs Holdings Inc. reported revenue of $14.8 million. It recorded a net loss of $12.2 million. The operating loss came to $4.8 million, an operating margin of -32.4%. Diluted earnings per share were -$8,108.26.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
Revenue
15
Cost of revenue
12
Gross profit
2
Research and development
5
Selling, general and administrative
2
Operating expenses
7
Operating income
-5
Pretax income
-12
Net income
-12
Basic EPS
-8,108.26
Diluted EPS
-8,108.26
Weighted average shares, basic
0
Weighted average shares, diluted
0
Other measures
Depreciation and amortization
0
EBITDA
-5
Margins
Gross margin
16.31%
Operating margin
-32.39%
Pretax margin
-82.05%
Profit margin
-82.05%
EBITDA margin
-32.34%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
XLAB (Nasdaq), XLABW (Nasdaq)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2109869
Former names
D. Boral ARC Merger Corp (until Jul 7, 2026)

Other Services-Prepackaged Software companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.